SUSQUEHANNA INTERNATIONAL GROUP, LLP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$159,513
-41.8%
53,171
-52.3%
0.00%
Q2 2023$274,049
+11.0%
111,402
+2.0%
0.00%
Q1 2023$246,824
-78.0%
109,214
-66.1%
0.00%
Q4 2022$1,124,112
-96.5%
322,095
-63.3%
0.00%
-100.0%
Q3 2022$32,519,000
+344.6%
878,418
+128.0%
0.01%
+300.0%
Q2 2022$7,315,000
+75.4%
385,200
+149.3%
0.00%
+100.0%
Q1 2022$4,170,000
-9.7%
154,500
-24.6%
0.00%
Q4 2021$4,618,000
+84.6%
204,910
+114.7%
0.00%
Q3 2021$2,501,000
-62.0%
95,430
-53.5%
0.00%
Q2 2021$6,574,000
+17.7%
205,361
+29.4%
0.00%
Q1 2021$5,587,000
+57.6%
158,678
+43.6%
0.00%
Q4 2020$3,544,000
+43.6%
110,512
+68.5%
0.00%
Q3 2020$2,468,000
-34.2%
65,600
-21.7%
0.00%
-100.0%
Q2 2020$3,750,000
+1.3%
83,800
-22.8%
0.00%0.0%
Q1 2020$3,703,000
+109.2%
108,566
+139.1%
0.00%
Q4 2019$1,770,00045,3990.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders